Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 143 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: R01 AG052962
NIAMS NIH HHS
Grant: R01 AR060636
National Institutes of Health
Grant: 5R01AG052962-03
TGF-beta family members and their binding proteins in aging skeletal muscle
National Institutes of Health
Grant: 5R01AR060636-20
Characterization of Myostatin and GDF-11
FWCI
6.66
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals